integrated within the bioMérieux Sepsis Solution enables same-day Antimicrobial Susceptibility Testing (AST) results to help you manage bloodstream infections.

▶️ Check out this video to discover the new instrument



Benefits - Specific Reveal



  • Delivers phenotypic AST results in an average of 5.5 hours*
  • Direct from positive blood culture

*Clinical evaluation of the SPECIFIC REVEAL™ with Gram-negative bacteremia samples in 6 hospitals in France and England - 2021



  • Wide antimicrobial coverage for Gram negative bloodstream infections
  • Allows faster antimicrobial therapy de-escalation to support antimicrobial stewardship
  • Real-time monitoring of Minimum Inhibitory Concentration (MIC) results



  • Fully integrated within the bioMérieux Sepsis Solution
  • Access to bioMérieux’s services from consultancy to installation
  • Bi-directional connectivity with MYLA® or LIS

How it works

The bioMérieux Sepsis Solution

The bioMérieux Sepsis Solution, with the addition of SPECIFIC REVEAL™ helps manage patient therapy all along the pathway, bringing you rapid and reliable results to support clinical decisions for better patient care.

Contact us

Fill in the form to be contacted by your bioMérieux representative

By submitting this form, you agree to the processing of your personal data in accordance with our Privacy Statement.